Cargando…

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer

PURPOSE: Medical oncology needs early identification of patients that are not responding to systemic therapy. (18)F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) performed before and early during treatment has been proposed for this purpose. However, the best way to assess the change i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buvat, Irène, Necib, Hatem, Garcia, Camilo, Wagner, Antoine, Vanderlinden, Bruno, Emonts, Patrick, Hendlisz, Alain, Flamen, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458195/ https://www.ncbi.nlm.nih.gov/pubmed/22710958 http://dx.doi.org/10.1007/s00259-012-2172-2

Ejemplares similares

Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
por: Maisonobe, Jacques-Antoine, et al.
Publicado: (2012)

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
por: Woff, Erwin, et al.
Publicado: (2016)

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study
por: Deleporte, Amelie, et al.
Publicado: (2014)

(90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2018)

Quantitative Evaluation of Therapeutic Response by FDG-PET–CT in Metastatic Breast Cancer
por: Goulon, Dorothée, et al.
Publicado: (2016)

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial (18)F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
por: Camera, Silvia, et al.
Publicado: (2020)

Prognostic value of a three-scale grading system based on combining molecular imaging with (68)Ga-DOTATATE and (18)F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias
por: Karfis, Ioannis, et al.
Publicado: (2020)

Role and interpretation of FDG-PET/CT in HIV patients with fever of unknown origin: a prospective study
por: Martin, C, et al.
Publicado: (2012)

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
por: Chan, David L., et al.
Publicado: (2022)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer
por: Soussan, Michael, et al.
Publicado: (2014)

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by (89)Zr-Trastuzumab and (18)F-FDG PET imaging
por: Wimana, Zéna, et al.
Publicado: (2017)

Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
por: Weber, Manuel, et al.
Publicado: (2021)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
por: Wallis, David, et al.
Publicado: (2021)

Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
por: Wallis, David, et al.
Publicado: (2022)

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
por: Hendlisz, Alain, et al.
Publicado: (2013)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

FDG-PET/CT findings of a metastatic pituitary tumor
por: Ilkhchoui, Yashar, et al.
Publicado: (2010)

(18)F-FDG PET/CT Findings of Leptomeningeal Metastasis in Nasopharyngeal Carcinoma
por: Montanarella, Matthew, et al.
Publicado: (2023)

Atypical Muscular Sarcoidosis Involvement Revealed by (18) F-FDG PET/CT
por: Lucinian, Yousif A., et al.
Publicado: (2022)

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
por: Herrmann, Ken, et al.
Publicado: (2015)

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors
por: Annovazzi, Alessio, et al.
Publicado: (2023)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

Identification of Metabolic Biomarkers Using Serial (18)F–FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2017)

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
por: Hendlisz, Alain, et al.
Publicado: (2015)

Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2020)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

Lymphomatoid Granulomatosis: CT and FDG-PET Findings
por: Chung, Jonathan H., et al.
Publicado: (2011)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

The Importance of FDG-PET/CT in Cogan’s Syndrome
por: Örsal, Ebru, et al.
Publicado: (2014)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

Role of FDG PET/CT in Baastrup's disease
por: Subramanyam, Padma, et al.
Publicado: (2016)

FDG PET/CT Findings in Biliary Papillomatosis
por: Tu, Zhuolong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5lhitv4lbvasoahrdb28gm32mr